These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


440 related items for PubMed ID: 21180035

  • 1. First orally active DRI Aliskiren--a new prospect in management of hypertension and beyond.
    Sawhney JP.
    Indian Heart J; 2010; 62(1):49-56. PubMed ID: 21180035
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS.
    J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
    [Abstract] [Full Text] [Related]

  • 3. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K.
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [Abstract] [Full Text] [Related]

  • 4. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
    Dalla Vestra M, Simioni N, Masiero A.
    Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162
    [Abstract] [Full Text] [Related]

  • 5. Clinical role of direct renin inhibition in hypertension.
    Taylor AA, Pool JL.
    Am J Ther; 2012 May; 19(3):204-10. PubMed ID: 21317620
    [Abstract] [Full Text] [Related]

  • 6. Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.
    Sanoski CA.
    Pharmacotherapy; 2009 Feb; 29(2):193-212. PubMed ID: 19170589
    [Abstract] [Full Text] [Related]

  • 7. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
    Horký K.
    Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
    [Abstract] [Full Text] [Related]

  • 8. Renin inhibition in hypertension.
    Gradman AH, Kad R.
    J Am Coll Cardiol; 2008 Feb 05; 51(5):519-28. PubMed ID: 18237679
    [Abstract] [Full Text] [Related]

  • 9. [The future of renin inhibition].
    Uresin AY, Baran E.
    Turk Kardiyol Dern Ars; 2009 Oct 05; 37 Suppl 7():32-8. PubMed ID: 20019475
    [Abstract] [Full Text] [Related]

  • 10. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK.
    Circulation; 2008 Jun 24; 117(25):3199-205. PubMed ID: 18559696
    [Abstract] [Full Text] [Related]

  • 11. Aliskiren: renin inhibitor for hypertension management.
    Cheng JW.
    Clin Ther; 2008 Jan 24; 30(1):31-47. PubMed ID: 18343241
    [Abstract] [Full Text] [Related]

  • 12. Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension.
    Riccioni G, Vitulano N, D'Orazio N, Bellocci F.
    Adv Ther; 2009 Jul 24; 26(7):700-10. PubMed ID: 19649581
    [Abstract] [Full Text] [Related]

  • 13. Aliskiren, the first direct renin inhibitor for treatment of hypertension: the path of its development.
    Jadhav M, Yeola C, Zope G, Nabar A.
    J Postgrad Med; 2012 Jul 24; 58(1):32-8. PubMed ID: 22387646
    [Abstract] [Full Text] [Related]

  • 14. Direct renin inhibition with aliskiren in hypertension and target organ damage.
    Müller DN, Luft FC.
    Clin J Am Soc Nephrol; 2006 Mar 24; 1(2):221-8. PubMed ID: 17699210
    [Abstract] [Full Text] [Related]

  • 15. Aliskiren in the management of hypertension.
    Barrios V, Escobar C.
    Am J Cardiovasc Drugs; 2010 Mar 24; 10(6):349-58. PubMed ID: 21090828
    [Abstract] [Full Text] [Related]

  • 16. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.
    McMurray JJ, Pitt B, Latini R, Maggioni AP, Solomon SD, Keefe DL, Ford J, Verma A, Lewsey J, Aliskiren Observation of Heart Failure Treatment (ALOFT) Investigators.
    Circ Heart Fail; 2008 May 24; 1(1):17-24. PubMed ID: 19808266
    [Abstract] [Full Text] [Related]

  • 17. Aliskiren, the future of renin-angiotensin system blockade?
    Uresin Y, Mehtar Bozkurt M, Sabirli S, Ozunal ZG.
    Expert Rev Cardiovasc Ther; 2007 Sep 24; 5(5):835-49. PubMed ID: 17867914
    [Abstract] [Full Text] [Related]

  • 18. Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trends.
    Gullapalli N, Bloch MJ, Basile J.
    Ther Adv Cardiovasc Dis; 2010 Dec 24; 4(6):359-73. PubMed ID: 20965951
    [Abstract] [Full Text] [Related]

  • 19. [Renin inhibitors--new direction in the treatment of arterial hypertension].
    Vasiuk IuA, Sadulaeva IA, Iushchuk EN, Trofimenko OS, Chirkov MV, Fedoseeva VS, Kulikov KG.
    Ter Arkh; 2010 Dec 24; 82(9):53-9. PubMed ID: 21086622
    [Abstract] [Full Text] [Related]

  • 20. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z, Armaly Z, Nakhoul F, Hoffman A.
    Harefuah; 2008 Jun 24; 147(6):536-42, 573. PubMed ID: 18693632
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.